309 related articles for article (PubMed ID: 30424007)
1. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
Cho HM; Seok YM; Lee HA; Song M; Kim I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
[TBL] [Abstract][Full Text] [Related]
2. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
3. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J
J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194
[TBL] [Abstract][Full Text] [Related]
4. FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.
Singh BK; Sinha RA; Zhou J; Xie SY; You SH; Gauthier K; Yen PM
J Biol Chem; 2013 Oct; 288(42):30365-30372. PubMed ID: 23995837
[TBL] [Abstract][Full Text] [Related]
5. HDAC4 mutations cause diabetes and induce β-cell FoxO1 nuclear exclusion.
Gong M; Yu Y; Liang L; Vuralli D; Froehler S; Kuehnen P; Du Bois P; Zhang J; Cao A; Liu Y; Hussain K; Fielitz J; Jia S; Chen W; Raile K
Mol Genet Genomic Med; 2019 May; 7(5):e602. PubMed ID: 30968599
[TBL] [Abstract][Full Text] [Related]
6. TRB1 negatively regulates gluconeogenesis by suppressing the transcriptional activity of FOXO1.
Tsuzuki K; Itoh Y; Inoue Y; Hayashi H
FEBS Lett; 2019 Feb; 593(3):369-380. PubMed ID: 30556236
[TBL] [Abstract][Full Text] [Related]
7. Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells.
Arai T; Kano F; Murata M
Genes Cells; 2015 Apr; 20(4):340-57. PubMed ID: 25736587
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
9. The Metabolic Regulator Histone Deacetylase 9 Contributes to Glucose Homeostasis Abnormality Induced by Hepatitis C Virus Infection.
Chen J; Wang N; Dong M; Guo M; Zhao Y; Zhuo Z; Zhang C; Chi X; Pan Y; Jiang J; Tang H; Niu J; Yang D; Li Z; Han X; Wang Q; Chen X
Diabetes; 2015 Dec; 64(12):4088-98. PubMed ID: 26420860
[TBL] [Abstract][Full Text] [Related]
10. Benzylglucosinolate Derived Isothiocyanate from Tropaeolum majus Reduces Gluconeogenic Gene and Protein Expression in Human Cells.
Guzmán-Pérez V; Bumke-Vogt C; Schreiner M; Mewis I; Borchert A; Pfeiffer AF
PLoS One; 2016; 11(9):e0162397. PubMed ID: 27622707
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibition ameliorates hypertension and hyperglycemia in a model of Cushing's syndrome.
Lee HA; Kang SH; Kim M; Lee E; Cho HM; Moon EK; Kim I
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E39-E52. PubMed ID: 28928236
[TBL] [Abstract][Full Text] [Related]
12. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
[TBL] [Abstract][Full Text] [Related]
13. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
Tian F; Ying HM; Wang YY; Cheng BN; Chen J
Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
Cai H; Jiang Z; Yang X; Lin J; Cai Q; Li X
Endocr J; 2020 Apr; 67(4):397-408. PubMed ID: 31875589
[TBL] [Abstract][Full Text] [Related]
15. The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver.
Oiso H; Furukawa N; Suefuji M; Shimoda S; Ito A; Furumai R; Nakagawa J; Yoshida M; Nishino N; Araki E
Biochem Biophys Res Commun; 2011 Jan; 404(1):166-72. PubMed ID: 21108932
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.
Nagashima T; Shigematsu N; Maruki R; Urano Y; Tanaka H; Shimaya A; Shimokawa T; Shibasaki M
Mol Pharmacol; 2010 Nov; 78(5):961-70. PubMed ID: 20736318
[TBL] [Abstract][Full Text] [Related]
17. Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis.
Chen J; Zhang Z; Wang N; Guo M; Chi X; Pan Y; Jiang J; Niu J; Ksimu S; Li JZ; Chen X; Wang Q
Sci Rep; 2017 Jul; 7(1):6102. PubMed ID: 28733598
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.
Lee HA; Lee DY; Cho HM; Kim SY; Iwasaki Y; Kim IK
Circ Res; 2013 Mar; 112(7):1004-12. PubMed ID: 23421989
[TBL] [Abstract][Full Text] [Related]
19. High glucose upregulates osteopontin expression by FoxO1 activation in macrophages.
Zhang Q; Wang C; Tang Y; Zhu Q; Li Y; Chen H; Bao Y; Xue S; Sun L; Tang W; Chen X; Shi Y; Qu L; Lu B; Zheng J
J Endocrinol; 2019 Aug; 242(2):51-64. PubMed ID: 31096186
[TBL] [Abstract][Full Text] [Related]
20. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat.
Khan S; Jena G; Tikoo K
Exp Mol Pathol; 2015 Apr; 98(2):230-9. PubMed ID: 25576297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
